APO Research
Talk to an analyst

APO RESEARCH · REPORT

Implantable Drug Eluting Balloon

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Implantable Drug Eluting Balloon Market Outlook and Growth Opportunities 2026

28 December 2025196 pages

Choose your research edition.

Industry ResearchImplantable Drug Eluting Balloon Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Implantable Drug Eluting Balloon Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Implantable Drug Eluting Balloon Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Implantable Drug Eluting Balloon Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Implantable Drug Eluting Balloon Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Implantable Drug Eluting Balloon market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Implantable Drug Eluting Balloon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Implantable Drug Eluting Balloon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Implantable Drug Eluting Balloon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Implantable Drug Eluting Balloon market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Implantable Drug Eluting Balloon market include Yinyi Biotech, Medtronic, Philips, Boston Scientific, B. Braun, Eurocor, BD, Aachen Resonance and Biotronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Implantable Drug Eluting Balloon market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Implantable Drug Eluting Balloon and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Implantable Drug Eluting Balloon sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Implantable Drug Eluting Balloon market size, projected growth trends, production technologies, key applications, and end-use industries.

Implantable Drug Eluting Balloon Segment by Company

Yinyi Biotech

Medtronic

Philips

Boston Scientific

B. Braun

Eurocor

BD

Aachen Resonance

Biotronic

Implantable Drug Eluting Balloon Segment by Type

Peripheral DEBs

Coronary DEBs

Implantable Drug Eluting Balloon Segment by Application

Catheterization Laboratory

Hospital

Other

Implantable Drug Eluting Balloon Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Implantable Drug Eluting Balloon status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Implantable Drug Eluting Balloon market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Implantable Drug Eluting Balloon significant trends, drivers, influence factors in global and regions.

6. To analyze Implantable Drug Eluting Balloon competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Drug Eluting Balloon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Implantable Drug Eluting Balloon and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Drug Eluting Balloon.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Implantable Drug Eluting Balloon market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Implantable Drug Eluting Balloon industry.

Chapter 3: Detailed analysis of Implantable Drug Eluting Balloon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Implantable Drug Eluting Balloon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Implantable Drug Eluting Balloon in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Implantable Drug Eluting Balloon Industry Trends Table 2. Implantable Drug Eluting Balloon Industry Drivers Table 3. Implantable Drug Eluting Balloon Industry Opportunities and Challenges Table 4. Implantable Drug Eluting Balloon Industry Restraints Table 5. Global Implantable Drug Eluting Balloon Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Implantable Drug Eluting Balloon Revenue Share by Company (2021-2026) Table 7. Global Implantable Drug Eluting Balloon Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Implantable Drug Eluting Balloon Sales Volume Share by Company (2021-2026) Table 9. Global Implantable Drug Eluting Balloon Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Implantable Drug Eluting Balloon Company Ranking, (2024-2026) & (USD Million) Table 11. Global Implantable Drug Eluting Balloon Key Company Manufacturing Base & Headquarters Table 12. Global Implantable Drug Eluting Balloon Company, Product Type & Application Table 13. Global Implantable Drug Eluting Balloon Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Implantable Drug Eluting Balloon by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Peripheral DEBs Table 18. Significant Companies of Coronary DEBs Table 19. Global Implantable Drug Eluting Balloon Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Implantable Drug Eluting Balloon Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Implantable Drug Eluting Balloon Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Implantable Drug Eluting Balloon Sales Volume Share by Type (2021-2026) Table 23. Global Implantable Drug Eluting Balloon Sales Volume Share by Type (2027-2032) Table 24. Global Implantable Drug Eluting Balloon Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Implantable Drug Eluting Balloon Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Implantable Drug Eluting Balloon Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Implantable Drug Eluting Balloon Sales Value Share by Type (2021-2026) Table 28. Global Implantable Drug Eluting Balloon Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Catheterization Laboratory Table 30. Significant Companies of Hospital Table 31. Significant Companies of Other Table 32. Global Implantable Drug Eluting Balloon Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Implantable Drug Eluting Balloon Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Implantable Drug Eluting Balloon Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Implantable Drug Eluting Balloon Sales Volume Share by Application (2021-2026) Table 36. Global Implantable Drug Eluting Balloon Sales Volume Share by Application (2027-2032) Table 37. Global Implantable Drug Eluting Balloon Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Implantable Drug Eluting Balloon Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Implantable Drug Eluting Balloon Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Implantable Drug Eluting Balloon Sales Value Share by Application (2021-2026) Table 41. Global Implantable Drug Eluting Balloon Sales Value Share by Application (2027-2032) Table 42. Global Implantable Drug Eluting Balloon Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Implantable Drug Eluting Balloon Sales by Region (2021-2026) & (K Units) Table 44. Global Implantable Drug Eluting Balloon Sales Market Share by Region (2021-2026) Table 45. Global Implantable Drug Eluting Balloon Sales by Region (2027-2032) & (K Units) Table 46. Global Implantable Drug Eluting Balloon Sales Market Share by Region (2027-2032) Table 47. Global Implantable Drug Eluting Balloon Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Implantable Drug Eluting Balloon Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Implantable Drug Eluting Balloon Sales Value Share by Region (2021-2026) Table 50. Global Implantable Drug Eluting Balloon Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Implantable Drug Eluting Balloon Sales Value Share by Region (2027-2032) Table 52. Global Implantable Drug Eluting Balloon Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Implantable Drug Eluting Balloon Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Implantable Drug Eluting Balloon Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Implantable Drug Eluting Balloon Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Implantable Drug Eluting Balloon Sales by Country (2021-2026) & (K Units) Table 57. Global Implantable Drug Eluting Balloon Sales Market Share by Country (2021-2026) Table 58. Global Implantable Drug Eluting Balloon Sales by Country (2027-2032) & (K Units) Table 59. Global Implantable Drug Eluting Balloon Sales Market Share by Country (2027-2032) Table 60. Global Implantable Drug Eluting Balloon Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Implantable Drug Eluting Balloon Sales Value Market Share by Country (2021-2026) Table 62. Global Implantable Drug Eluting Balloon Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Implantable Drug Eluting Balloon Sales Value Market Share by Country (2027-2032) Table 64. Yinyi Biotech Company Information Table 65. Yinyi Biotech Business Overview Table 66. Yinyi Biotech Implantable Drug Eluting Balloon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Yinyi Biotech Implantable Drug Eluting Balloon Product Portfolio Table 68. Yinyi Biotech Recent Development Table 69. Medtronic Company Information Table 70. Medtronic Business Overview Table 71. Medtronic Implantable Drug Eluting Balloon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Medtronic Implantable Drug Eluting Balloon Product Portfolio Table 73. Medtronic Recent Development Table 74. Philips Company Information Table 75. Philips Business Overview Table 76. Philips Implantable Drug Eluting Balloon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Philips Implantable Drug Eluting Balloon Product Portfolio Table 78. Philips Recent Development Table 79. Boston Scientific Company Information Table 80. Boston Scientific Business Overview Table 81. Boston Scientific Implantable Drug Eluting Balloon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Boston Scientific Implantable Drug Eluting Balloon Product Portfolio Table 83. Boston Scientific Recent Development Table 84. B. Braun Company Information Table 85. B. Braun Business Overview Table 86. B. Braun Implantable Drug Eluting Balloon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. B. Braun Implantable Drug Eluting Balloon Product Portfolio Table 88. B. Braun Recent Development Table 89. Eurocor Company Information Table 90. Eurocor Business Overview Table 91. Eurocor Implantable Drug Eluting Balloon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Eurocor Implantable Drug Eluting Balloon Product Portfolio Table 93. Eurocor Recent Development Table 94. BD Company Information Table 95. BD Business Overview Table 96. BD Implantable Drug Eluting Balloon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. BD Implantable Drug Eluting Balloon Product Portfolio Table 98. BD Recent Development Table 99. Aachen Resonance Company Information Table 100. Aachen Resonance Business Overview Table 101. Aachen Resonance Implantable Drug Eluting Balloon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Aachen Resonance Implantable Drug Eluting Balloon Product Portfolio Table 103. Aachen Resonance Recent Development Table 104. Biotronic Company Information Table 105. Biotronic Business Overview Table 106. Biotronic Implantable Drug Eluting Balloon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Biotronic Implantable Drug Eluting Balloon Product Portfolio Table 108. Biotronic Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Implantable Drug Eluting Balloon Distributors List Table 112. Implantable Drug Eluting Balloon Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Implantable Drug Eluting Balloon Product Image Figure 2. Global Implantable Drug Eluting Balloon Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Implantable Drug Eluting Balloon Sales Value (2021-2032) & (US$ Million) Figure 4. Global Implantable Drug Eluting Balloon Sales (2021-2032) & (K Units) Figure 5. Global Implantable Drug Eluting Balloon Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Implantable Drug Eluting Balloon Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Peripheral DEBs Image Figure 10. Coronary DEBs Image Figure 11. Global Implantable Drug Eluting Balloon Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Implantable Drug Eluting Balloon Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Implantable Drug Eluting Balloon Sales Volume Share by Type (2021-2032) Figure 14. Global Implantable Drug Eluting Balloon Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Implantable Drug Eluting Balloon Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Implantable Drug Eluting Balloon Sales Value Share by Type (2021-2032) Figure 17. Catheterization Laboratory Image Figure 18. Hospital Image Figure 19. Other Image Figure 20. Global Implantable Drug Eluting Balloon Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Implantable Drug Eluting Balloon Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Implantable Drug Eluting Balloon Sales Volume Share by Application (2021-2032) Figure 23. Global Implantable Drug Eluting Balloon Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Implantable Drug Eluting Balloon Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Implantable Drug Eluting Balloon Sales Value Share by Application (2021-2032) Figure 26. Global Implantable Drug Eluting Balloon Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Implantable Drug Eluting Balloon Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Implantable Drug Eluting Balloon Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Implantable Drug Eluting Balloon Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Implantable Drug Eluting Balloon Sales Value (2021-2032) & (US$ Million) Figure 31. North America Implantable Drug Eluting Balloon Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Implantable Drug Eluting Balloon Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Implantable Drug Eluting Balloon Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Implantable Drug Eluting Balloon Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Implantable Drug Eluting Balloon Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Implantable Drug Eluting Balloon Sales Value (2021-2032) & (US$ Million) Figure 37. South America Implantable Drug Eluting Balloon Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Implantable Drug Eluting Balloon Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Implantable Drug Eluting Balloon Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Implantable Drug Eluting Balloon Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Implantable Drug Eluting Balloon Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Peripheral DEBs
  • Coronary DEBs
Applications
  • Catheterization Laboratory
  • Hospital
  • Other
Companies covered
  • Yinyi Biotech
  • Medtronic
  • Philips
  • Boston Scientific
  • B. Braun
  • Eurocor
  • BD
  • Aachen Resonance
  • Biotronic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Implantable Drug Eluting Balloon Sales Value (2021-2032)
  4. 1.2.2 Global Implantable Drug Eluting Balloon Sales Volume (2021-2032)
  5. 1.2.3 Global Implantable Drug Eluting Balloon Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Implantable Drug Eluting Balloon Market Dynamics
  1. 2.1 Implantable Drug Eluting Balloon Industry Trends
  2. 2.2 Implantable Drug Eluting Balloon Industry Drivers
  3. 2.3 Implantable Drug Eluting Balloon Industry Opportunities and Challenges
  4. 2.4 Implantable Drug Eluting Balloon Industry Restraints
3 Implantable Drug Eluting Balloon Market by Company
  1. 3.1 Global Implantable Drug Eluting Balloon Company Revenue Ranking in 2025
  2. 3.2 Global Implantable Drug Eluting Balloon Revenue by Company (2021-2026)
  3. 3.3 Global Implantable Drug Eluting Balloon Sales Volume by Company (2021-2026)
  4. 3.4 Global Implantable Drug Eluting Balloon Average Price by Company (2021-2026)
  5. 3.5 Global Implantable Drug Eluting Balloon Company Ranking (2024-2026)
  6. 3.6 Global Implantable Drug Eluting Balloon Company Manufacturing Base and Headquarters
  7. 3.7 Global Implantable Drug Eluting Balloon Company Product Type and Application
  8. 3.8 Global Implantable Drug Eluting Balloon Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Implantable Drug Eluting Balloon Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Implantable Drug Eluting Balloon Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Implantable Drug Eluting Balloon Market by Type
  1. 4.1 Implantable Drug Eluting Balloon Type Introduction
  2. 4.1.1 Peripheral DEBs
  3. 4.1.2 Coronary DEBs
  4. 4.2 Global Implantable Drug Eluting Balloon Sales Volume by Type
  5. 4.2.1 Global Implantable Drug Eluting Balloon Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Implantable Drug Eluting Balloon Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Implantable Drug Eluting Balloon Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Implantable Drug Eluting Balloon Sales Value by Type
  9. 4.3.1 Global Implantable Drug Eluting Balloon Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Implantable Drug Eluting Balloon Sales Value by Type (2021-2032)
  11. 4.3.3 Global Implantable Drug Eluting Balloon Sales Value Share by Type (2021-2032)
5 Implantable Drug Eluting Balloon Market by Application
  1. 5.1 Implantable Drug Eluting Balloon Application Introduction
  2. 5.1.1 Catheterization Laboratory
  3. 5.1.2 Hospital
  4. 5.1.3 Other
  5. 5.2 Global Implantable Drug Eluting Balloon Sales Volume by Application
  6. 5.2.1 Global Implantable Drug Eluting Balloon Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Implantable Drug Eluting Balloon Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Implantable Drug Eluting Balloon Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Implantable Drug Eluting Balloon Sales Value by Application
  10. 5.3.1 Global Implantable Drug Eluting Balloon Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Implantable Drug Eluting Balloon Sales Value by Application (2021-2032)
  12. 5.3.3 Global Implantable Drug Eluting Balloon Sales Value Share by Application (2021-2032)
6 Implantable Drug Eluting Balloon Regional Sales and Value Analysis
  1. 6.1 Global Implantable Drug Eluting Balloon Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Implantable Drug Eluting Balloon Sales by Region (2021-2032)
  3. 6.2.1 Global Implantable Drug Eluting Balloon Sales by Region: 2021-2026
  4. 6.2.2 Global Implantable Drug Eluting Balloon Sales by Region (2027-2032)
  5. 6.3 Global Implantable Drug Eluting Balloon Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Implantable Drug Eluting Balloon Sales Value by Region (2021-2032)
  7. 6.4.1 Global Implantable Drug Eluting Balloon Sales Value by Region: 2021-2026
  8. 6.4.2 Global Implantable Drug Eluting Balloon Sales Value by Region (2027-2032)
  9. 6.5 Global Implantable Drug Eluting Balloon Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Implantable Drug Eluting Balloon Sales Value (2021-2032)
  12. 6.6.2 North America Implantable Drug Eluting Balloon Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Implantable Drug Eluting Balloon Sales Value (2021-2032)
  15. 6.7.2 Europe Implantable Drug Eluting Balloon Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Implantable Drug Eluting Balloon Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Implantable Drug Eluting Balloon Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Implantable Drug Eluting Balloon Sales Value (2021-2032)
  21. 6.9.2 South America Implantable Drug Eluting Balloon Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Implantable Drug Eluting Balloon Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Implantable Drug Eluting Balloon Sales Value Share by Country, 2025 VS 2032
7 Implantable Drug Eluting Balloon Country-level Sales and Value Analysis
  1. 7.1 Global Implantable Drug Eluting Balloon Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Implantable Drug Eluting Balloon Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Implantable Drug Eluting Balloon Sales by Country (2021-2032)
  4. 7.3.1 Global Implantable Drug Eluting Balloon Sales by Country (2021-2026)
  5. 7.3.2 Global Implantable Drug Eluting Balloon Sales by Country (2027-2032)
  6. 7.4 Global Implantable Drug Eluting Balloon Sales Value by Country (2021-2032)
  7. 7.4.1 Global Implantable Drug Eluting Balloon Sales Value by Country (2021-2026)
  8. 7.4.2 Global Implantable Drug Eluting Balloon Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Implantable Drug Eluting Balloon Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Implantable Drug Eluting Balloon Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Implantable Drug Eluting Balloon Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yinyi Biotech
  2. 8.1.1 Yinyi Biotech Company Information
  3. 8.1.2 Yinyi Biotech Business Overview
  4. 8.1.3 Yinyi Biotech Implantable Drug Eluting Balloon Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yinyi Biotech Implantable Drug Eluting Balloon Product Portfolio
  6. 8.1.5 Yinyi Biotech Recent Developments
  7. 8.2 Medtronic
  8. 8.2.1 Medtronic Company Information
  9. 8.2.2 Medtronic Business Overview
  10. 8.2.3 Medtronic Implantable Drug Eluting Balloon Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Medtronic Implantable Drug Eluting Balloon Product Portfolio
  12. 8.2.5 Medtronic Recent Developments
  13. 8.3 Philips
  14. 8.3.1 Philips Company Information
  15. 8.3.2 Philips Business Overview
  16. 8.3.3 Philips Implantable Drug Eluting Balloon Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Philips Implantable Drug Eluting Balloon Product Portfolio
  18. 8.3.5 Philips Recent Developments
  19. 8.4 Boston Scientific
  20. 8.4.1 Boston Scientific Company Information
  21. 8.4.2 Boston Scientific Business Overview
  22. 8.4.3 Boston Scientific Implantable Drug Eluting Balloon Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Boston Scientific Implantable Drug Eluting Balloon Product Portfolio
  24. 8.4.5 Boston Scientific Recent Developments
  25. 8.5 B. Braun
  26. 8.5.1 B. Braun Company Information
  27. 8.5.2 B. Braun Business Overview
  28. 8.5.3 B. Braun Implantable Drug Eluting Balloon Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 B. Braun Implantable Drug Eluting Balloon Product Portfolio
  30. 8.5.5 B. Braun Recent Developments
  31. 8.6 Eurocor
  32. 8.6.1 Eurocor Company Information
  33. 8.6.2 Eurocor Business Overview
  34. 8.6.3 Eurocor Implantable Drug Eluting Balloon Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Eurocor Implantable Drug Eluting Balloon Product Portfolio
  36. 8.6.5 Eurocor Recent Developments
  37. 8.7 BD
  38. 8.7.1 BD Company Information
  39. 8.7.2 BD Business Overview
  40. 8.7.3 BD Implantable Drug Eluting Balloon Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 BD Implantable Drug Eluting Balloon Product Portfolio
  42. 8.7.5 BD Recent Developments
  43. 8.8 Aachen Resonance
  44. 8.8.1 Aachen Resonance Company Information
  45. 8.8.2 Aachen Resonance Business Overview
  46. 8.8.3 Aachen Resonance Implantable Drug Eluting Balloon Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Aachen Resonance Implantable Drug Eluting Balloon Product Portfolio
  48. 8.8.5 Aachen Resonance Recent Developments
  49. 8.9 Biotronic
  50. 8.9.1 Biotronic Company Information
  51. 8.9.2 Biotronic Business Overview
  52. 8.9.3 Biotronic Implantable Drug Eluting Balloon Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Biotronic Implantable Drug Eluting Balloon Product Portfolio
  54. 8.9.5 Biotronic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Implantable Drug Eluting Balloon Value Chain Analysis
  2. 9.1.1 Implantable Drug Eluting Balloon Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Implantable Drug Eluting Balloon Sales Mode & Process
  6. 9.2 Implantable Drug Eluting Balloon Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Implantable Drug Eluting Balloon Distributors
  9. 9.2.3 Implantable Drug Eluting Balloon Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst